These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25603995)

  • 21. High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing.
    Jun HR; Kang HJ; Ju SH; Kim JE; Jeon SY; Ku B; Lee JJ; Kim M; Kim MJ; Choi JJ; Noh JJ; Kim HS; Lee JW; Lee JK; Lee DW
    Biomaterials; 2023 May; 296():122087. PubMed ID: 36924663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An emerging role for cytopathology in precision oncology.
    Pauli C; Puca L; Mosquera JM; Robinson BD; Beltran H; Rubin MA; Rao RA
    Cancer Cytopathol; 2016 Mar; 124(3):167-73. PubMed ID: 26641771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammary Tumor Organoid Culture in Non-Adhesive Alginate for Luminal Mechanics and High-Throughput Drug Screening.
    Fang G; Lu H; Rodriguez de la Fuente L; Law AMK; Lin G; Jin D; Gallego-Ortega D
    Adv Sci (Weinh); 2021 Nov; 8(21):e2102418. PubMed ID: 34494727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antiproliferation in prostate cancer cell lines with cytostatics and combinations with resistance modifiers.
    Pintér O; Mucsi I; Molnár J
    In Vivo; 2005; 19(1):253-9. PubMed ID: 15796183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor organoids: Opportunities and challenges to guide precision medicine.
    Veninga V; Voest EE
    Cancer Cell; 2021 Sep; 39(9):1190-1201. PubMed ID: 34416168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapeutic inhibitors in the treatment of prostate cancer.
    Deshmukh RR; Schmitt SM; Hwang C; Dou QP
    Expert Opin Pharmacother; 2014 Jan; 15(1):11-22. PubMed ID: 24156780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors.
    Centenera MM; Gillis JL; Hanson AR; Jindal S; Taylor RA; Risbridger GP; Sutherland PD; Scher HI; Raj GV; Knudsen KE; Yeadon T; ; Tilley WD; Butler LM
    Clin Cancer Res; 2012 Jul; 18(13):3562-70. PubMed ID: 22573351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personalizing prostate cancer therapy: the way forward.
    Cetnar JP; Beer TM
    Drug Discov Today; 2014 Sep; 19(9):1483-7. PubMed ID: 25046532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform.
    Chua CW; Chiu YT; Yuen HF; Chan KW; Man K; Wang X; Ling MT; Wong YC
    Clin Cancer Res; 2009 Jul; 15(13):4322-35. PubMed ID: 19509141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colon cancer organoids using monoclonal organoids established in four different lesions of one cancer patient reveal tumor heterogeneity and different real-time responsiveness to anti-cancer drugs.
    Song MH; Park JW; Kim MJ; Shin YK; Kim SC; Jeong SY; Ku JL
    Biomed Pharmacother; 2022 Aug; 152():113260. PubMed ID: 35691158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids.
    Bulin AL; Broekgaarden M; Hasan T
    Sci Rep; 2017 Nov; 7(1):16645. PubMed ID: 29192263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment Selection.
    Johnson KA; DeStefanis RA; Emmerich PB; Grogan PT; Kratz JD; Makkar SK; Clipson L; Deming DA
    Curr Treat Options Oncol; 2020 Apr; 21(5):35. PubMed ID: 32328818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
    Sachs N; de Ligt J; Kopper O; Gogola E; Bounova G; Weeber F; Balgobind AV; Wind K; Gracanin A; Begthel H; Korving J; van Boxtel R; Duarte AA; Lelieveld D; van Hoeck A; Ernst RF; Blokzijl F; Nijman IJ; Hoogstraat M; van de Ven M; Egan DA; Zinzalla V; Moll J; Boj SF; Voest EE; Wessels L; van Diest PJ; Rottenberg S; Vries RGJ; Cuppen E; Clevers H
    Cell; 2018 Jan; 172(1-2):373-386.e10. PubMed ID: 29224780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics.
    Fitzgerald KA; Guo J; Tierney EG; Curtin CM; Malhotra M; Darcy R; O'Brien FJ; O'Driscoll CM
    Biomaterials; 2015 Oct; 66():53-66. PubMed ID: 26196533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer.
    Wadosky KM; Wang Y; Zhang X; Goodrich DW
    J Vis Exp; 2019 Jun; (148):. PubMed ID: 31259888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishing Pure Cancer Organoid Cultures: Identification, Selection and Verification of Cancer Phenotypes and Genotypes.
    Wallaschek N; Niklas C; Pompaiah M; Wiegering A; Germer CT; Kircher S; Brändlein S; Maurus K; Rosenwald A; Yan HHN; Leung SY; Bartfeld S
    J Mol Biol; 2019 Jul; 431(15):2884-2893. PubMed ID: 31150736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer.
    Singh T; Neal AS; Moatamed NA; Memarzadeh S
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted Therapies for Prostate Cancer.
    Petrioli R; Francini E; Fiaschi AI; Laera L; Roviello G
    Cancer Invest; 2015; 33(7):276-85. PubMed ID: 25951372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer organoids make debut.
    Cancer Discov; 2014 Nov; 4(11):1248. PubMed ID: 25367931
    [No Abstract]   [Full Text] [Related]  

  • 40. Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer.
    Msaouel P; Nandikolla G; Pneumaticos SG; Koutsilieris M
    Expert Opin Investig Drugs; 2013 Nov; 22(11):1385-400. PubMed ID: 24024652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.